Two PE majors, buyout-backed Stada enter final bidding for €1bn-valued Bristol-Myers Squibb drug unit

Buyout majors CVC Capital Partners and PAI Partners are reportedly still in the running for the French over-the-counter drugs business of Bristol-Myers Squibb as it enters the final round.